Form D · Private Equity Fund

Adjuvant Global Health Technology Fund, L.P.

New York, NY · CIK 0001783165

Offering snapshot reported Feb 23, 2021 · SEC filing

Reported sold
$252M
Offering amount: $252M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 20, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$126M$252MAug 5, 2019Jan 17, 2020: $168,500,000.00Jan 17, 2020Feb 23, 2021: $251,773,050.00Feb 23, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$168,500,000 → $251,773,050
  • Reported investors16 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 23, 2021Amendment$251,773,050$83,273,050vs Jan 17, 202021SEC filing
Jan 17, 2020Amendment$168,500,000No comparison16SEC filing
Aug 5, 2019InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-345780

Source: Form D, filed Feb 23, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.

Investment adviser: ADJUVANT CAPITAL, LP

Gross asset value
$143M
Beneficial owners
24
ADV minimum commitment
$5M

Reported in Form ADV on Mar 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CARTA FUND SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG, LLP GEORGE TOWN, Cayman Islands
Custodian FIRST-CITIZENS BANK & TRUST COMPANY NEW YORK, New York, United States Related to adviser: No
Custodian JPMORGAN CHASE & CO NEW YORK, New York, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SRS ACQUIOM, INC. SAN FRANCISCO, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG, LLP
PCAOB 1323

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

Filing source

Form ADV 2075732 · Mar 27, 2026 · Schedule D 7.B.(1), fund 805-3999922832

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Glenn Rockman Executive
Jenny Yip Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Adjuvant Capital, L.P. 501 Fifth Avenue, Suite 1404
New York, NY, 10017